NEW YORK (GenomeWeb) – Biocept today announced it has reached agreements with preferred provider organizations Stratose and Galaxy Health Network, who cover 12 million members combined, to provide access to the firm's non-invasive liquid biopsy testing. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.